Hollsteen
← onsemi

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 2016: $1.7B · 10-Q 0001193125-16-583131 filed May 9, 2016Equity incl. NCI · Q2 2016: $1.7B · 10-Q 0001193125-16-674368 filed Aug 8, 2016Equity incl. NCI · Q3 2016: $1.8B · 10-Q 0001193125-16-761289 filed Nov 7, 2016Equity incl. NCI · Q4 2016: $1.8B · 10-K 0001193125-17-062207 filed Feb 28, 2017Equity incl. NCI · Q1 2017: $2.0B · 10-Q 0001193125-17-162150 filed May 8, 2017Equity incl. NCI · Q2 2017: $2.1B · 10-Q 0001193125-17-249592 filed Aug 7, 2017Equity incl. NCI · Q3 2017: $2.2B · 10-Q 0001193125-17-333825 filed Nov 6, 2017Equity incl. NCI · Q4 2017: $2.8B · 10-K 0001193125-18-051397 filed Feb 21, 2018Equity incl. NCI · Q1 2018: $3.0B · 10-Q 0001193125-18-141784 filed Apr 30, 2018Equity incl. NCI · Q2 2018: $3.1B · 10-Q 0001193125-18-230892 filed Jul 30, 2018Equity incl. NCI · Q3 2018: $3.2B · 10-Q 0001193125-18-310159 filed Oct 29, 2018Equity incl. NCI · Q4 2018: $3.2B · 10-K 0001193125-19-045025 filed Feb 20, 2019Equity incl. NCI · Q1 2019: $3.2B · 10-Q 0001193125-19-124388 filed Apr 29, 2019Equity incl. NCI · Q2 2019: $3.3B · 10-Q 0001193125-19-212847 filed Aug 5, 2019Equity incl. NCI · Q3 2019: $3.2B · 10-Q 0001193125-19-275863 filed Oct 28, 2019Equity incl. NCI · Q4 2019: $3.3B · 10-K 0001193125-20-041751 filed Feb 19, 2020Equity incl. NCI · Q1 2020: $3.2B · 10-Q 0001628280-20-007369 filed May 11, 2020Equity incl. NCI · Q2 2020: $3.3B · 10-Q 0001628280-20-012282 filed Aug 10, 2020Equity incl. NCI · Q3 2020: $3.4B · 10-Q 0001628280-20-015208 filed Nov 2, 2020Equity incl. NCI · Q4 2020: $3.6B · 10-K 0001628280-21-002219 filed Feb 16, 2021Equity incl. NCI · Q1 2021: $3.6B · 10-Q 0001628280-21-008547 filed May 3, 2021Equity incl. NCI · Q2 2021: $3.8B · 10-Q 0001628280-21-015118 filed Aug 2, 2021Equity incl. NCI · Q3 2021: $4.1B · 10-Q 0001628280-21-020929 filed Nov 1, 2021Equity incl. NCI · Q4 2021: $4.6B · 10-K 0001628280-22-002416 filed Feb 14, 2022Equity incl. NCI · Q1 2022: $5.0B · 10-Q 0001628280-22-011616 filed May 2, 2022Equity incl. NCI · Q2 2022: $5.4B · 10-Q 0001628280-22-019900 filed Aug 1, 2022Equity incl. NCI · Q3 2022: $5.7B · 10-Q 0001628280-22-027363 filed Oct 31, 2022Equity incl. NCI · Q4 2022: $6.2B · 10-K 0001628280-23-002350 filed Feb 6, 2023Equity incl. NCI · Q1 2023: $6.5B · 10-Q 0001628280-23-014387 filed May 1, 2023Equity incl. NCI · Q2 2023: $7.0B · 10-Q 0001628280-23-026196 filed Jul 31, 2023Equity incl. NCI · Q3 2023: $7.5B · 10-Q 0001628280-23-035450 filed Oct 30, 2023Equity incl. NCI · Q4 2023: $7.8B · 10-K 0001628280-24-003201 filed Feb 5, 2024Equity incl. NCI · Q1 2024: $8.1B · 10-Q 0001628280-24-018814 filed Apr 29, 2024Equity incl. NCI · Q2 2024: $8.4B · 10-Q 0001628280-24-033229 filed Jul 29, 2024Equity incl. NCI · Q3 2024: $8.6B · 10-Q 0001628280-24-043880 filed Oct 28, 2024Equity incl. NCI · Q4 2024: $8.8B · 10-K 0001628280-25-004557 filed Feb 10, 2025Equity incl. NCI · Q1 2025: $8.0B · 10-Q 0001628280-25-022042 filed May 5, 2025Equity incl. NCI · Q2 2025: $8.0B · 10-Q 0001097864-25-000013 filed Aug 4, 2025Equity incl. NCI · Q3 2025: $7.9B · 10-Q 0001097864-25-000019 filed Nov 3, 2025Equity incl. NCI · Q4 2025: $7.7B · 10-K 0001097864-26-000006 filed Feb 9, 2026Equity incl. NCI · Q1 2026: $7.3B · 10-Q 0001097864-26-000014 filed May 4, 2026Equity incl. NCI · Q2 2026: $7.2B · 10-Q 0001097864-26-000017 filed Aug 3, 20268,0497,2381,6788,814Q1 2016Q2 2026Q1 2025
$MEquity incl. NCI · Q3 2024: $8.6B · 10-Q 0001628280-24-043880 filed Oct 28, 2024Equity incl. NCI · Q4 2024: $8.8B · 10-K 0001628280-25-004557 filed Feb 10, 2025Equity incl. NCI · Q1 2025: $8.0B · 10-Q 0001628280-25-022042 filed May 5, 2025Equity incl. NCI · Q2 2025: $8.0B · 10-Q 0001097864-25-000013 filed Aug 4, 2025Equity incl. NCI · Q3 2025: $7.9B · 10-Q 0001097864-25-000019 filed Nov 3, 2025Equity incl. NCI · Q4 2025: $7.7B · 10-K 0001097864-26-000006 filed Feb 9, 2026Equity incl. NCI · Q1 2026: $7.3B · 10-Q 0001097864-26-000014 filed May 4, 2026Equity incl. NCI · Q2 2026: $7.2B · 10-Q 0001097864-26-000017 filed Aug 3, 20268,0497,2388,604Q3 2024Q2 2026Q1 2025
Q1 2025
8,049$M
All values (42)
PeriodValue ($M)Status
Q2 20267,238reported
Q1 20267,321reported
Q4 20257,692reported
Q3 20257,926reported
Q2 20257,961reported
Q1 20258,049reported
Q4 20248,814reported
Q3 20248,604reported
Q2 20248,358reported
Q1 20248,143reported
Q4 20237,801reported
Q3 20237,504reported
Q2 20237,004reported
Q1 20236,467reported
Q4 20226,207reported
Q3 20225,677reported
Q2 20225,410reported
Q1 20225,018reported
Q4 20214,604reported
Q3 20214,144reported
Q2 20213,804reported
Q1 20213,650reported
Q4 20203,558reported
Q3 20203,447reported
Q2 20203,259reported
Q1 20203,238reported
Q4 20193,324reported
Q3 20193,240reported
Q2 20193,298reported
Q1 20193,221reported
Q4 20183,194reported
Q3 20183,203reported
Q2 20183,097reported
Q1 20182,952reported
Q4 20172,801reported
Q3 20172,235reported
Q2 20172,119reported
Q1 20171,998reported
Q4 20161,845reported
Q3 20161,754reported
Q2 20161,726reported
Q1 20161,678reported

CSV with all sources · Technical ID: equity_total

More metrics for onsemi

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$8.0B
Period
Q1 2025, ended Apr 4, 2025 · as of Apr 4, 2025 (balance as of date, not a sum)
Source
10-Q, filed May 5, 2025 · 0001628280-25-022042
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$8.0BMay 5, 202510-Q 0001628280-25-022042reported · confidence 1. · current